STRS Ohio’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

STRS Ohio’s Portfolio RXDX Stock Details RXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,700	Closed	-$719K	–	2166
2023 Q1	$719K	Buy	6,700 +4,000	+148%	+$460K	﹤0.01%	1082
2022 Q4	$297K	Sell	2,700 -4,700	-64%	-$305K	﹤0.01%	1499
2022 Q3	$436K	Hold	7,400	–	–	﹤0.01%	1376
2022 Q2	$208K	Buy	7,400 +400	+6%	+$11.6K	﹤0.01%	1600
2022 Q1	$264K	Hold	7,000	–	–	﹤0.01%	1634
2021 Q4	$276K	Buy	7,000 +4,400	+169%	+$138K	﹤0.01%	1643
2021 Q3	$61K	Hold	2,600	–	–	﹤0.01%	2039
2021 Q2	$63K	Buy	+2,600	New	+$58K	﹤0.01%	2069

Other funds holding RXDX

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

STRS Ohio's RXDX Position: Q2 2023 in Review

STRS Ohio sold out of Prometheus Biosciences, Inc. Common Stock (RXDX) in Q2 2023, closing a stake of 6,700 shares — an estimated $719K sold.

STRS Ohio first reported a position in RXDX in Q2 2021 and held it in 8 quarters. The position peaked at $719K in Q1 2023. 2 funds tracked by Wall St. Rank hold RXDX as of Q2 2023.

STRS Ohio reported no remaining Prometheus Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
STRS Ohio sold 6,700 Prometheus Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $719K.
STRS Ohio first reported a position in Prometheus Biosciences, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
STRS Ohio's Prometheus Biosciences, Inc. Common Stock position peaked at $719K in Q1 2023.
2 funds tracked by Wall St. Rank held Prometheus Biosciences, Inc. Common Stock as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.